Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
Main Authors: | Salnikov, A V, Bretz, N P, Perne, C, Hazin, J, Keller, S, Fogel, M, Herr, I, Schlange, T, Moldenhauer, G, Altevogt, P |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629417/ |
Similar Items
-
Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer
by: Herr, Ingrid, et al.
Published: (2012) -
Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
by: Salnikov, Alexei V, et al.
Published: (2009) -
Politics, Efficiency, and Retardation
by: Arnold, Felix
Published: (1913) -
The financial milieu of the IASB and AASB
by: Brown, Alistair
Published: (2006) -
The milieu of government reporting in Vanuatu
by: Brown, Alistair
Published: (2011)